"To our knowledge, Inverness has not initiated clinical trials designed for submission for FDA marketing clearance; however, in December 2009, we will begin to earn an annual minimal royalty payment of $150,000."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.